News Release: Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.18 per Common Share for 3Q22
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.18 per Common Share for 3Q22, for an Aggregate of $4.66 per Common Share for the 12 Months Ending September 30, 2022, Up 24 Cents, or 5 Percent, Over the 12 Months Ended September 30, 2021 NEWS PROVIDED BY Alexandria Real Estate Equities, Inc. Sep 06, 2022, […]
News Release: BGL Managing Director Jonathan Bluth Speaking at the Annual Healthcare Leadership & Executive Conference
The Zephyr Healthcare Advisors Annual Healthcare Leadership & Executive Conference – produced by Zephyr Healthcare Advisors – brings together leadership and experts in the healthcare industry to discuss the successes and challenges of healthcare transformation and care delivery. BGL Managing Director Jonathan Bluth will be a featured panelist for the session at this year’s conference […]
Life Sciences: Filling a void in the emerging Boulder, Colo., LSRE market
BREI talks with Ben Rosenfield and Bill Jencks about PMB’s new $280M development By Murray W. Wolf San Diego-based PMB, a longtime healthcare real estate (HRE) developer, and Montgomery Street Partners, a real estate private equity firm with offices in Dallas and New York, announced Wednesday (Aug. 31) that they have received town board approval […]
News Release: PMB and Montgomery Street Partners announce approval on the first speculative purpose-built life sciences project in Boulder County, CO
FOR IMMEDIATE RELEASE This new 365,000 sq. ft. facility in Boulder County will break ground in Q2 of 2023 and complete in Q3 of 2024 SUPERIOR, CO, Aug 31, 2022 – PMB, a leading healthcare real estate developer, in partnership with Montgomery Street Partners, received Superior Town Board approval on its final development plan for […]
Life Sciences: Topping Off Held For Watertown Life Science Campus
August 26th, 2022 | by High-Profile Watertown, MA – The Davis Companies and Boston Development Group (BDG) recently celebrated the ceremonial topping-off of Phase One of 66 Galen Street in Watertown, a 224,000rsf, purpose-built, Class A life science building designed by Elkus Manfredi Architects. This milestone marks the completion of the structural phase of construction […]
News Release: Mayor Adams Invests $27 Million To Accelerate Growth Of Life Sciences In NY
August 24, 2022 City Awards to City College and Mount Sinai Will Create Hundreds of Jobs and Support New Startups and Next Generation of Innovation and Research Mayor Adams’ Vision Has NYC on Path to Become Global Leader in Life Sciences, Create 40,000 Family-Sustaining Jobs in Next Decade NEW YORK – New York City Mayor […]
News Release: Acquisition of future Houston-area cGMP life science facility closes
JLL Capital Markets arranged the acquisition of the 76,000-square-foot 9501 Lakeside Blvd. in The Woodlands, Texas WASHINGTON, D.C., August 24, 2022 – JLL Capital Markets announced today that it has closed the acquisition of 9501 Lakeside, a future 76,000-square-foot, cell therapy manufacturing facility located in The Woodlands within the Houston, Texas, MSA. JLL represented the […]
News Release: COMMONWEALTH SELECTS PARTNER FOR TRANSFORMATION OF HURLEY BUILDING
$1B+ Project Will Activate an Underutilized Site in Downtown Boston with Life Sciences & Mixed-Use Redevelopment, Solving Decades of Site Challenges BOSTON, Aug. 24, 2022- Today, the Baker Polito Administration announced the designation of Leggat McCall Properties (LMP) as the Commonwealth’s partner to redevelop the Charles F. Hurley Building. The project will catalyze substantial economic […]
News Release: Sonoma Biotherapeutics Signs Long-Term Lease to Create New 83,000-SF Treg Cell Therapy R&D and Manufacturing Center in Seattle
Cushman & Wakefield and JLL represented the tenant in the long-term lease transaction SEATTLE, Wash., August 24, 2022 – Cushman & Wakefield and JLL today jointly announced that the firms have represented Sonoma Biotherapeutics, Inc. in a long-term lease agreement to develop an approximately 83,000-square-foot Research and Development (R&D) and Manufacturing Center in Seattle, Washington. […]
News Release:Sonoma Biotherapeutics Enters Long-Term Lease Agreement to Establish a Treg Cell Therapy R&D and Manufacturing Center
Center will be devoted to research, development and manufacturing of novel regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases Center will house a cGMP-compliant manufacturing facility designed to produce cell products at scale for upcoming clinical trials across Sonoma Bio’s gene-modified Treg programs SOUTH SAN FRANCISCO, Calif. & SEATTLE, Aug. 24, 2022–(BUSINESS WIRE)–Sonoma […]
News Release: Keystone Development + Investment Secures $265.2M Loan to Expand the Life Science Conversion of The Curtis
August 24, 2022 08:48 AM Eastern Daylight Time CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Keystone Development + Investment has secured a $265.2 million loan from Nuveen Real Estate, an affiliate of Teachers Insurance & Annuity Associates of America (TIAA), to expand its Life Science conversion of The Curtis in Philadelphia, and to construct the mission-critical infrastructure required for the […]
News Release: CBRE Expands Healthcare and Life Sciences Platform in Houston with Hire of Walker Pennington
HOUSTON, Aug. 18, 2022 — CBRE announced today that Walker Pennington has joined CBRE’s Healthcare and Life Sciences team in Houston as a Senior Associate. Mr. Pennington’s healthcare-specific real estate experience brings immediate value to the team as the industry continues to grow in Houston. He will partner with Scott Carter, Nelson Udstuen, and Brandy Bellow […]
News Release: VGXI Announces Grand Opening Celebration for New Headquarters and Manufacturing Facility
Specialized plasmid DNA contract manufacturer VGXI, Inc. announces date for the Grand Opening celebration of its new headquarters and expanded manufacturing facility in Conroe, TX. CONROE, TEXAS (PRWEB) AUGUST 17, 2022 — VGXI, Inc., an industry-leading contract developer and manufacturer (CDMO) of nucleic acid biopharmaceuticals including gene therapies, DNA vaccines, and RNA medicines, announces the […]
News Release: Cellipont Announces Plans for Commercial-Ready Cell Therapy Facility in Houston
Cellipont Bioservices, a leading cell therapy contract development and manufacturing services company, is planning a new commercial-ready site in The Woodlands, Texas. POWAY, CA – August 17, 2022 –Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), today announced plans for a 76,000 sq. ft. commercial-ready manufacturing facility for cell therapies and gene-modified […]
News Release: WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware
MIDDLETOWN, Delaware, August 16, 2022 – WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the groundbreaking for its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware. First announced in June 2021, this site will be WuXi STA’s second facility in the United States, offering expanded capacity and greater […]